Pregled bibliografske jedinice broj: 850901
The Tolerability and Safety of Repeated Sputum Induction in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease
The Tolerability and Safety of Repeated Sputum Induction in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease // IOSR journal of dental and medical sciences, 15 (2016), 10; 61-66 doi:10.9790/0853-1510016166 (podatak o recenziji nije dostupan, članak, znanstveni)
CROSBI ID: 850901 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The Tolerability and Safety of Repeated Sputum Induction in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease
Autori
Friedrich, Latica ; Popović-Grle, Sanja ; Manojlović, Zoran ; Konjevoda, Paško ; Orešković, Katarina
Izvornik
IOSR journal of dental and medical sciences (2279-0853) 15
(2016), 10;
61-66
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
lung function ; sputum ; lung diseases obstructive
Sažetak
Background: Sputum induction is a method used over the years to investigate airway inflammation in patients with asthma and chronic obstructive pulmonary disease (COPD), to establish correct disease phenotype. Sputum production and expectoration are induced by inhaling hypertonic saline, which can also provoke adverse effects such as bronchoconstriction, lung hyperinflation, and dyspnea. The aim of this retrospective study was to assess the tolerability and safety of sputum induction in patients with more severe COPD stages. Methods: A total of 76 sputum inductions were performed in 20 patients with moderate or severe COPD (median FEV1 1.6 L [95%CI 1.47-1.71]or 51% [95% CI 47-54%] of predicted) over a period of 32 days. Unique advantage of this study is multiple sputum induction in same patient. After premedication with 200 µg salbutamol, subjects inhaled increasing concentrations of aerosolized saline (0.9%, 3%, 4% and 5%), each for 7 minutes. FEV1 was recorded prior to induction and after each inhalation interval. Results: The median fall of FEV1 at the end of sputum induction was 127 mL (95%CI 90-176 mL) or 10% (95%CI 7-11%) from baseline post-bronchodilator value. In 11 cases (14%) the procedure was terminated due to an excessive bronchoconstriction (fall in FEV1>20% from baseline). None of the subjects reported adverse events. Conclusions: Sputum induction is safe and well tolerated by patients with moderate to severe COPD, which supports its use in clinical and research practice. Patients with a more severe airway obstruction may have a higher risk of excessive bronchoconstriction, precaution measures should be anticipated in those patients.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Institut "Ruđer Bošković", Zagreb,
Klinička bolnica "Sveti Duh",
Klinički bolnički centar Zagreb
Profili:
Zoran Manojlović
(autor)
Katarina Orešković
(autor)
Paško Konjevoda
(autor)
Sanja Popović-Grle
(autor)